Filter Results:
(2,085)
Show Results For
- All HBS Web
(2,085)
- People (8)
- News (589)
- Research (988)
- Events (3)
- Multimedia (25)
- Faculty Publications (582)
Show Results For
- All HBS Web
(2,085)
- People (8)
- News (589)
- Research (988)
- Events (3)
- Multimedia (25)
- Faculty Publications (582)
- 2024
- Article
Beyond the 510(k): The Regulation of Novel Moderate-Risk Medical Devices, Intellectual Property Considerations, and Innovation Incentives in the FDA’s De Novo Pathway
By: Mateo Aboy, Cristina Crespo and Ariel Stern
Moderate-risk medical devices constitute 99% of those that have been regulated by the U.S. Food and Drug Administration (FDA) since it gained authority to regulate medical technology nearly five decades ago. This article presents an analysis of the interaction between... View Details
Keywords: Governing Rules, Regulations, and Reforms; Health Care and Treatment; Technology Adoption; Technological Innovation; Safety; Medical Devices and Supplies Industry; United States
Aboy, Mateo, Cristina Crespo, and Ariel Stern. "Beyond the 510(k): The Regulation of Novel Moderate-Risk Medical Devices, Intellectual Property Considerations, and Innovation Incentives in the FDA’s De Novo Pathway." Art. 29. npj Digital Medicine 7 (2024).
- Web
Degrees, Certifications & Alumni Status | About
Graduate School of Arts and Sciences offers PhD programs that reflect the changing world of business, society, and education. PhD programs are offered in the following areas: Accounting & Management, Business Economics (includes Finance), View Details
- 13 Jan 2003
- Research & Ideas
The Subconscious Mind of the Consumer (And How To Reach It)
about consumer behavior and in using that knowledge to benefit consumers. These firms include McNeil Consumer Health Care, McCann-Erickson, Procter & Gamble, Hallmark, Bank of America, Kraft, Samsung Electronics, IBM, Pfizer, J.... View Details
Keywords: by Manda Mahoney
- Program
Agribusiness Seminar
constraints Leverage data and technology to improve decision making, operating efficiency, and responsiveness to customers Defend against commodification and drive profitability through product and marketing innovation Design robust,... View Details
- July 1994 (Revised March 1996)
- Case
Baxter International: OnCall as Soon as Possible?
Baxter Healthcare is heir to the fabled ASAP ordering system, one of the best-known examples of the use of technology to provide strategic marketing advantage. By 1994, the proprietary ASAP system is well established. Baxter is beginning to launch On-Call EDI, which is... View Details
Keywords: Information Technology; Competitive Advantage; Business Strategy; Information Technology Industry; Information Technology Industry
Sviokla, John J., and Chris L Marshall. "Baxter International: OnCall as Soon as Possible?" Harvard Business School Case 195-103, July 1994. (Revised March 1996.)
- 12 Jan 2022
- News
Harvard Business School’s Bold Agenda
Paul A. Gompers
Paul Gompers, Professor of Business Administration at the Harvard Business School, specializes in research on financial issues related to start-up, high growth, and newly public companies. Professor Gompers has an appointment in both the View Details
Keywords: health care; health care; health care; health care; health care; health care; health care; health care
- Web
Marketing - Faculty & Research
FDA approval to bring his technology to patients in the US. As time ticked by, GLP-1 drugs came like a tsunami, seemingly conquering the weight-loss market. With approval seemingly coming soon, Gaur had to decide what his strategy should... View Details
- Web
Podcasts - Managing the Future of Work
retention. Also, how technology can accelerate the adoption. Read the Transcript Previous Episodes The business logic of supporting carers in the workforce 23 OCT 2024 | Managing the Future of Work Employers can benefit by remapping their... View Details
- Web
Publications - Institute For Strategy And Competitiveness
Article The Agenda for the Next Generation of Health Care Information Technology The Agenda for the Next Generation of Health Care Information View Details
- 23 Jul 2020
- Blog Post
Why Plume? To Make a Difference in the World
cancelled and recruiting heated up, I continued to find myself thinking about Plume. Each case in Strategy and TEM transformed into a lens through which I looked at our mission and market. Midway through the semester, I joined the team formally as Head of Growth. Plume... View Details
- August 2024
- Case
Sky Therapeutics: Innovating in Digital Therapeutics
By: Satish Tadikonda, Olivia Reszczynski and William Marks
Shad Faraz and Alex Youssef were intrigued by the opportunities in the relatively new area of Digital Therapeutics. Despite initial successes, early entrants had struggled with reimbursement and revenue-predictability challenges. However, venture investors still... View Details
- 21 Jun 2017
- News
A New Approach to Safely Sharing Cancer Patients’ Data
- 06 Mar 2012
- First Look
First Look: March 6
productive. The authors have studied when 161 countries adopted 104 technologies over the past 200 years, and they conclude that profound economic advantages-as measured by per capita income-accrue to early adopters of technology. Read... View Details
Keywords: Sean Silverthorne
- May 2023 (Revised June 2023)
- Case
Novartis (A): Reimagining Medicine
By: Ramon Casadesus-Masanell, Claudio Feser, Karolin Frankenberger and David Redaschi
This case unfolds around the first-ever approved personalized cancer treatment, how Novartis wrapped it into a new business model design, and how Novartis scaled it. Novartis — one of the largest pharmaceutical companies in the world — is, among other ventures,... View Details
Keywords: Health Care and Treatment; Business Model; Leadership; Pharmaceutical Industry; Switzerland
Casadesus-Masanell, Ramon, Claudio Feser, Karolin Frankenberger, and David Redaschi. "Novartis (A): Reimagining Medicine." Harvard Business School Case 723-443, May 2023. (Revised June 2023.)
- Web
Program Requirements - Doctoral
Health Policy (Management) Program Requirements Students in the Health Policy (Management) program will learn how theories and concepts from fields such as technology and... View Details
- Article
Beyond Statistics: The Economic Content of Risk Scores
By: Liran Einav, Amy Finkelstein, Raymond Kluender and Paul Schrimpf
"Big data" and statistical techniques to score potential transactions have transformed insurance and credit markets. In this paper, we observe that these widely-used statistical scores summarize a much richer heterogeneity, and may be endogenous to the context in which... View Details
Einav, Liran, Amy Finkelstein, Raymond Kluender, and Paul Schrimpf. "Beyond Statistics: The Economic Content of Risk Scores." American Economic Journal: Applied Economics 8, no. 2 (April 2016): 195–224.
- Web
Key Concepts - Institute For Strategy And Competitiveness
Measure Outcomes & Cost for Every Patient Aligning Reimbursement with Value Systems Integration Geography of Care Information Technology Key Concepts Value-based health care is one of the most important... View Details
- December 2003 (Revised April 2004)
- Case
Dragon's Teeth Vineyards
By: Alan D. MacCormack, Marius Leibold, Sven Voelpel and Kerry Herman
Dragon's Teeth Vineyards (DTV) is a South African wine producer that is considering whether to use genetically modified organisms (GMOs) in its wine-making process. GMOs promise to lower the costs of wine production significantly through increased yields and reduced... View Details
Keywords: Technological Innovation; Growth and Development Strategy; Genetics; Transition; Brands and Branding; Product Development; Product Design; Organizational Change and Adaptation; Technology Adoption; Food and Beverage Industry; Biotechnology Industry; South Africa
MacCormack, Alan D., Marius Leibold, Sven Voelpel, and Kerry Herman. "Dragon's Teeth Vineyards." Harvard Business School Case 604-069, December 2003. (Revised April 2004.)
- 11 Nov 2014
- First Look
First Look: November 11
reached their limits; third, some products affecting the health and rights of the people as well as the related entities' behavior are challenging the legal and moral bottom line. These three aspects are required to establish a new... View Details
Keywords: Sean Silverthorne